Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Keramida K, Farmakis D, Rakisheva A, Tocchetti CG, Ameri P, Asteggiano R, Barac A, Bax J, Bayes-Genis A, Bergler Klein J, Bucciarelli-Ducci C, Celutkiene J, Coats AJS, Cohen Solal A, Dent S, Filippatos G, Ghosh A, Hermann J, Koop Y, Lenihan D, Lopez Fernandez T, Lyon AR, Mercurio V, Moura B, Piepoli M, Sener YZ, Suter T, Sverdlov AL, Tadic M, Thum T, van der Meer P, van Linthout S, Metra M, Rosano G. Keramida K, et al. Among authors: suter t. Eur J Heart Fail. 2024 Oct;26(10):2077-2093. doi: 10.1002/ejhf.3412. Epub 2024 Aug 28. Eur J Heart Fail. 2024. PMID: 39193837 No abstract available.
End-of-life preferences of elderly patients with chronic heart failure.
Brunner-La Rocca HP, Rickenbacher P, Muzzarelli S, Schindler R, Maeder MT, Jeker U, Kiowski W, Leventhal ME, Pfister O, Osswald S, Pfisterer ME, Rickli H; TIME-CHF Investigators. Brunner-La Rocca HP, et al. Eur Heart J. 2012 Mar;33(6):752-9. doi: 10.1093/eurheartj/ehr404. Epub 2011 Nov 8. Eur Heart J. 2012. PMID: 22067089 Clinical Trial.
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron.
Sloop KW, Cox AL, Wainscott DB, White A, Droz BA, Stutsman C, Showalter AD, Suter TM, Dunbar JD, Snider BM, O'Farrell LS, Hewitt N, Ruble JC, Padgett LR, Woerly EM, Peterson JA, Coskun T, Liu Z, Coutant DE, Ai M, Emmerson PJ, Sangwung P, Willard FS. Sloop KW, et al. Among authors: suter tm. Sci Transl Med. 2024 Dec 18;16(778):eadp5765. doi: 10.1126/scitranslmed.adp5765. Epub 2024 Dec 18. Sci Transl Med. 2024. PMID: 39693407
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.
Loibl S, Jassem J, Sonnenblick A, Parlier D, Winer E, Bergh J, Gelber RD, Restuccia E, Im YH, Huang CS, Dalenc F, Calvo I, Procter M, Caballero C, Clark E, Raimbault A, McConnell R, Monturus E, de Azambuja E, Gomez HL, Bliss J, Viale G, Bines J, Piccart M; APHINITY Steering Committee and Investigators. Loibl S, et al. J Clin Oncol. 2024 Nov;42(31):3643-3651. doi: 10.1200/JCO.23.02505. Epub 2024 Sep 11. J Clin Oncol. 2024. PMID: 39259927 Clinical Trial.
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study.
Kraler S, Liberale L, Nopp S, Englisch C, Grilz E, Lapikova-Bryhinska T, Akhmedov A, Carbone F, Ramoni D, Tirandi A, Scuricini A, Isoppo S, Tortorella C, La Rosa F, Michelauz C, Frè F, Gavoci A, Lisa A, Suter TM, von Eckardstein A, Wenzl FA, Pabinger I, Lüscher TF, Montecucco F, Ay C, Moik F. Kraler S, et al. Among authors: suter tm. J Thromb Haemost. 2024 Nov;22(11):3125-3136. doi: 10.1016/j.jtha.2024.07.019. Epub 2024 Sep 1. J Thromb Haemost. 2024. PMID: 39223063 Free article.
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR. Tocchetti CG, et al. Among authors: suter t. Eur J Heart Fail. 2024 Oct;26(10):2055-2076. doi: 10.1002/ejhf.3340. Epub 2024 Aug 1. Eur J Heart Fail. 2024. PMID: 39087551 Review.
Response to Fu and Zheng regarding: "The effect of intravenous tranexamic acid on visual clarity in arthroscopic shoulder surgery compared to epinephrine and a placebo: a double-blinded, randomized controlled trial".
Suter T, McRae S, Zhang Y, MacDonald PB, Woodmass JM, Mutter TC, Wolfe S, Marsh J, Dubberley J, Old J. Suter T, et al. J Shoulder Elbow Surg. 2024 Sep;33(9):e521. doi: 10.1016/j.jse.2024.03.071. Epub 2024 Jun 4. J Shoulder Elbow Surg. 2024. PMID: 38844156 No abstract available.
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.
Pizzamiglio S, Ciniselli CM, de Azambuja E, Agbor-Tarh D, Moreno-Aspitia A, Suter TM, Trama A, De Santis MC, De Cecco L, Iorio MV, Silvestri M, Pruneri G, Verderio P, Di Cosimo S. Pizzamiglio S, et al. Among authors: suter tm. Breast Cancer Res Treat. 2024 Jul;206(2):285-294. doi: 10.1007/s10549-024-07299-6. Epub 2024 Apr 30. Breast Cancer Res Treat. 2024. PMID: 38689174 Free PMC article.
230 results